Skip to content
★ Sign in to follow
서

서영교

원바이오젠
Total declarations
3
Company
1
▲ Purchases (3 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 14 Aug 2024 for 원바이오젠.

서영교: trading record in brief

서영교 appears in our data through filings on 원바이오젠 shares, published by DART (FSS). In total, 3 filings cover trades dated from 1 October 2021 to 29 March 2023.

The open-market record is one-sided, with 3 purchases and not one sale. The totals exclude 3 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 1 purchase and no sales.

No cluster: in 3 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 14 August 2024, reports an open-market purchase in 원바이오젠. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 서영교

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    사내이사Executives(filed)원바이오젠
    7DART
    ShareKRXDART:20240814002349
    Canonical exit: 12 Nov 2024 (T+90)
  • ▲
    사내이사Executives(filed)원바이오젠
    7DART
    ShareKRXDART:20221222000570
    Canonical exit: 22 Mar 2023 (T+90)
  • ▲
    사내이사Executives(filed)원바이오젠
    7DART
    ShareKRXDART:20211001000266
    Canonical exit: 30 Dec 2021 (T+90)

3 of 3 declarations